R&D Implementation System
Program Structure
Full-Stage
R&D
NDIT Pursues an End-to-End Development Ecosystem that Seamlessly Bridges the Gap between Discovery to Clinical Application
01
Platform Technologies
Development of CAR-T, TCR-T,
and TIL platform technologies
Establishment of tumor and neoantigen analysis system
Establishment of tumor and neoantigen analysis system
02
Preclinical & Technology Validation
Preclinical safety assessment
Mechanism-of-action analysis and evidence for clinical translation
Mechanism-of-action analysis and evidence for clinical translation
03
CMC & QC Infrastructure
Establishment of clinical-grade cell
and vector manufacturing processes
Development of QC standards and quality criteria
Development of QC standards and quality criteria
04
Clinical Research Infrastructure
Protocol writing, GMP manufacturing capabilities,
and regulatory alignment
Patient enrollment, safety monitoring, and data management systems
Patient enrollment, safety monitoring, and data management systems
05
Commercialization
& Patient Access
& Patient Access
Regulatory and policy strategy for commercialization
Improved patient access to treatment
Improved patient access to treatment
06
Cross-Sector
Collaboration
Collaboration
Integration across research, manufacturing, and clinical application through Industry–Academia–Research–Hospital Collaboration